Your Doctor Thinks Ozempic Is Cheating. They’re Wrong

Transcript

Send us Fan Mail

This episode examines GLP-1 medications for obesity, discussing its complexities as a chronic disease. Dr. Khan and the host highlight the need for compassionate, informed care rather than viewing obesity as a personal failure.

In this episode, I dig into a topic I hear about constantly in clinic: GLP-1 medications like Ozempic and Mounjaro, and why there is still so much confusion and judgment around treating obesity. This episode was sparked by a conversation I had with another physician that honestly stopped me in my tracks. They suggested the obesity epidemic could be solved if people just ate better and exercised. That kind of thinking is common, but it is also a major oversimplification, and it ignores what we actually know about obesity as a disease. That moment pushed me to take a deeper look at what is really driving obesity and why medical treatment matters. I am joined by Dr Khan, a primary care physician who speaks directly to this issue. Together, we walk through why obesity is not a character flaw or a simple lifestyle problem. It is a complex, chronic disease shaped by genetics, behavior, nutrition, metabolism, environment, and mental health. Dr Khan explains why blaming individuals is not only inaccurate but also harmful, and why it keeps patients from getting the medicine they need to treat a medical condition. My goal is for clinicians to be allies in this fight, and for patients to feel supported, informed, and taken seriously.

💡 Start your journey today with Maryland Primary Care & Wellness
Book your consultation: https://www.maryland-primarycare.com/